Bialonczyk C - Search Results

1

The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease.

Stain M, Schönauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. Stain M, et al. Among authors: bialonczyk c. J Thromb Haemost. 2005 Dec;3(12):2671-6. doi: 10.1111/j.1538-7836.2005.01648.x. J Thromb Haemost. 2005. PMID: 16359506 Free article.

2

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.

Eichinger S, Weltermann A, Mannhalter C, Minar E, Bialonczyk C, Hirschl M, Schönauer V, Lechner K, Kyrle PA. Eichinger S, et al. Among authors: bialonczyk c. Arch Intern Med. 2002 Nov 11;162(20):2357-60. doi: 10.1001/archinte.162.20.2357. Arch Intern Med. 2002. PMID: 12418950

3

Superficial thrombophlebitis and risk for recurrent venous thromboembolism.

Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Partsch H, Eichinger S. Schönauer V, et al. Among authors: bialonczyk c. J Vasc Surg. 2003 Apr;37(4):834-8. doi: 10.1067/mva.2003.157. J Vasc Surg. 2003. PMID: 12663985 Free article.

4

D-dimer levels and risk of recurrent venous thromboembolism.

Eichinger S, Minar E, Bialonczyk C, Hirschl M, Quehenberger P, Schneider B, Weltermann A, Wagner O, Kyrle PA. Eichinger S, et al. Among authors: bialonczyk c. JAMA. 2003 Aug 27;290(8):1071-4. doi: 10.1001/jama.290.8.1071. JAMA. 2003. PMID: 12941680

5

Thrombin-activatable fibrinolysis inhibitor and the risk for recurrent venous thromboembolism.

Eichinger S, Schönauer V, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Schneider B, Quehenberger P, Kyrle PA. Eichinger S, et al. Among authors: bialonczyk c. Blood. 2004 May 15;103(10):3773-6. doi: 10.1182/blood-2003-10-3422. Epub 2004 Jan 22. Blood. 2004. PMID: 14739223 Free article.

6

The risk of recurrent venous thromboembolism in men and women.

Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. Kyrle PA, et al. Among authors: bialonczyk c. N Engl J Med. 2004 Jun 17;350(25):2558-63. doi: 10.1056/NEJMoa032959. N Engl J Med. 2004. PMID: 15201412 Free article.

7

Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism.

Vormittag R, Vukovich T, Schönauer V, Lehr S, Minar E, Bialonczyk C, Hirschl M, Pabinger I. Vormittag R, et al. Among authors: bialonczyk c. Thromb Haemost. 2005 Mar;93(3):488-93. doi: 10.1160/TH04-11-0745. Thromb Haemost. 2005. PMID: 15735799

8

Family history for venous thromboembolism and the risk for recurrence.

Hron G, Eichinger S, Weltermann A, Minar E, Bialonczyk C, Hirschl M, Stain M, Gartner V, Kyrle PA. Hron G, et al. Among authors: bialonczyk c. Am J Med. 2006 Jan;119(1):50-3. doi: 10.1016/j.amjmed.2005.04.043. Am J Med. 2006. PMID: 16431184

9

Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism.

Vormittag R, Hsieh K, Kaider A, Minar E, Bialonczyk C, Hirschl M, Mannhalter C, Pabinger I. Vormittag R, et al. Among authors: bialonczyk c. Thromb Haemost. 2006 May;95(5):802-6. Thromb Haemost. 2006. PMID: 16676071

10

Prediction of recurrent venous thromboembolism by measuring ProC Global.

Eichinger S, Hron G, Hirschl M, Bialonczyk C, Minar E, Kollars M, Kyrle PA. Eichinger S, et al. Among authors: bialonczyk c. Thromb Haemost. 2007 Dec;98(6):1232-6. doi: 10.1160/th07-05-0376. Thromb Haemost. 2007. PMID: 18064319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters